Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
Simmons Cancer Institute at Southern Illinois University, Springfield, Illinois, USA.
Clin Infect Dis. 2023 Jul 26;77(2):237-241. doi: 10.1093/cid/ciad185.
Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) use between October and December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations and was strongly associated with older age and increased disease severity. There were disparities in the receipt of CCP by race and ethnicity, geography, and insurance.
2020 年 10 月至 12 月期间，使用全国住院患者样本数据库对冠状病毒病 2019（COVID-19）恢复期血浆（CCP）的使用情况进行了描述。在与 COVID-19 相关的住院治疗中，有 18.0%使用了 CCP，并且 CCP 与年龄较大和疾病严重程度增加密切相关。在接受 CCP 治疗方面存在种族和民族、地理位置和保险方面的差异。
